| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 699,800 | 719,300 | 693,000 | | Cost of Revenue | 244,600 | 236,100 | 247,600 | | | Gross Profit | 455,200 | 483,200 | 445,400 | | | Operating Expenses | | Research Development | 17,600 | 18,400 | 15,300 | | Selling General and Administrative | 270,200 | 254,400 | 241,300 | | Non Recurring | 7,700 | (7,700) |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 159,700 | 218,100 | 188,800 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 159,700 | 218,100 | 188,800 | | Interest Expense | 23,000 | 24,300 | 28,000 | | Income Before Tax | 136,700 | 193,800 | 160,800 | | Income Tax Expense | 37,900 | 55,800 | 54,200 | | Minority Interest | (7,800) |
-
|
-
| | | | Net Income From Continuing Ops | 91,000 | 138,000 | 106,600 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 91,000 | 138,000 | 106,600 | | Preferred Stock And Other Adjustments | 6,600 | (3,500) | (3,100) | | | Net Income Applicable To Common Shares | $97,600 | $134,500 | $103,500 |
|
0.51% Nasdaq 
0.16 (0.37%) 
Income Statement
